Abstract
Variants leading to FGFR2 exon 18 truncation function as an oncogenic driver mutation.
©2022 American Association for Cancer Research
2022
American Association for Cancer Research
You do not currently have access to this content.
Skip Nav Destination
Article navigation
1 October 2022
Research Watch|
October 05 2022
FGFR2 Exon 18 Truncation Variants Are Therapeutically Actionable in Cancer
Cancer Discov (2022) 12 (10): 2233.
RSS Feeds